Disclosure 0002012524-26-000008-1

SEC FORM 4

$106,073.10

Theravance Biopharma, Inc. (TBPH)

Disposition (code F) of 6,258 shares at $16.95 per share.

Reporting Person Miller Aine · Officer Title SVP, DEV & HEAD OF IRE OFFICE · Transaction Code F

Traded Aug 20, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0002012524-26-000008 · filed 2026-08-24 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Theravance Biopharma, Inc. (TBPH)." Disclosed 2026-08-24. https://desqlong.com/cards/0002012524-26-000008-1 (retrieved 2026-09-26).